At Algenuity, we specialize in multiparametric optimization and take a radically different statistical modeling approach to help you get the most from your algal strains. We can improve your process and outcome by discovering which parameters are most important and co-optimizing them, while also uncovering hidden parameter interactions. We statistically model your process to accurately predict better conditions, which rapidly increases your yields, defines tolerances, improves your process economics and decreases your time to market.

We have demonstrated successful application of this advanced scientific approach to increase the biomass yield of Arthrospira platensis (Spirulina) by 235% and productivity of Haematococcus pluvialis to 6.9% dry weight astaxanthin. “We are excited by the outcomes we have achieved for two commercially important microalgae, and we are confident to apply our knowhow and technology to improve microalgal industry outputs across the board, driving the industry into success, renewed investment, and growth”, stated Andrew Spicer, Algenuity CEO. Come along to this year’s ABO Summit and meet us at Booth #416 to see how we can optimize your strain, improve your outputs, and support you in your ultimate success story.

Algenuity is an algae technology development and licensing company with world-class expertise in algal biotechnology, solving problems that deliver a positive global impact. Algenuity’s multidisciplinary team develops proprietary and integrated solutions that increase productivity and performance of algal strains, reduce time to market for algal bioproducts, and boost overall profitability. These enabling technologies include the Algem® labscale photobioreactor, a non-GM directed evolution platform, GM strain engineering platforms, and novel bioprocess development and optimisation tools. Algenuity is located in Stewartby, Bedfordshire, within the United Kingdom’s Golden Triangle for biotech between London, Cambridge, and Oxford.

For more information, visit www.algenuity.com